SARS CoV 2 News and Research

RSS

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection.

10 Mar 2022

New study analyzes COVID-19 outcomes in patients with cancer

If a cancer patient tests positive for COVID-19, are they more likely to become hospitalized from the disease?

10 Mar 2022

Study finds fewer COVID-19 cases in schools with mandatory masking during Delta surge

Schools with mandatory masking during the Delta surge had approximately 72% fewer cases of in-school transmission of SARS-CoV-2 when compared to schools with optional or partial masking policies, according to a study funded by the National Institutes of Health.

10 Mar 2022

Study shows vaccine effectiveness against SARS-CoV-2 and severe disease in dialysis patients

Multiple studies have shown that individuals with kidney failure who are undergoing dialysis mount weaker antibody responses after COVID-19 vaccination than people in the general population, but new research indicates that these individuals' immune responses are still capable of protecting against SARS-CoV-2 infection and severe COVID-19.

10 Mar 2022

Three vaccine doses are crucial to achieve effective protection against omicron

mRNA vaccines are highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. But three doses are needed to achieve a similar level of protection against omicron that two doses provide against the delta and alpha variants, finds a large US study published by The BMJ today.

10 Mar 2022

Long-lasting immune activity in the airways may be the cause of persistent post-COVID-19 breathlessness

Long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19.

10 Mar 2022

Tannic acid plays a role in inhibiting three key molecular pathways involved in SARS-CoV-2 infection

Professor Charles Ramassamy and his postdoctoral researcher Mohamed Haddad at Institut national de la recherche scientifique, in collaboration with scientists from Université de Montréal, McGill University, and Université du Québec à Montréal, believe that tannic acid plays a role in inhibiting three important molecular pathways involved in the SARS-CoV-2 infection.

10 Mar 2022

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Researchers demonstrated the anti-spike antibody response to SARS-CoV-2 infection and further estimated the acute SARS-CoV-2 infection-induced Ab activity against recently emerged variants like Omicron.

10 Mar 2022

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

In a new study, researchers presented the origins and evolution of the SARS-CoV-2 lineage B.1.1.7 in the United Kingdom.

10 Mar 2022

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

LMU scientists have investigated how most people's immune defenses are able to curb the coronavirus so effectively that pneumonia does not occur.

10 Mar 2022

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

New research discusses the role of mutations in the receptor-binding domain of the spike protein in the generation of antibody resistance and loss of vaccine efficacy.

10 Mar 2022

Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

A recent study simulated the superspreading dynamics of COVID-19.

10 Mar 2022

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Researchers explored strategies to develop an mRNA-based COVID-19 vaccine that could elicit safer and wider protection against SARS-CoV-2 variants of concern.

10 Mar 2022

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

New research describes a novel approach whereby SARS-2 antigens were analyzed for conserved sites that may be targeted by broadly neutralizing antibodies that will confer immunity to other Sarbecoviruses.

10 Mar 2022

Quantification of hydrophobic interactions encoded by FP1 sequences of SARS-CoV-2 and MERS-CoV by single-molecule force measurements

Researchers quantified hydrophobic interactions encoded by fusion peptide 1 sequences of SARS-CoV-2 and MERS-CoV using single-molecule force measurements.

10 Mar 2022

SARS CoV 2 News and Research

Most cancer patients develop antibodies after receiving COVID-19 vaccine, study shows

New study analyzes COVID-19 outcomes in patients with cancer

Study finds fewer COVID-19 cases in schools with mandatory masking during Delta surge

Study shows vaccine effectiveness against SARS-CoV-2 and severe disease in dialysis patients

Three vaccine doses are crucial to achieve effective protection against omicron

Long-lasting immune activity in the airways may be the cause of persistent post-COVID-19 breathlessness

Tannic acid plays a role in inhibiting three key molecular pathways involved in SARS-CoV-2 infection

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Quantification of hydrophobic interactions encoded by FP1 sequences of SARS-CoV-2 and MERS-CoV by single-molecule force measurements

How does COVID-19 affect arrythmia?

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

The trajectory of B-cell immunity six months after mRNA vaccination

Long COVID symptoms in families a year after SARS-CoV-2 infection or household exposure

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News